Roivant Sciences Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 800
Employees
  • Stock Symbol
  • ROIV
Stock Symbol
  • Investments
  • 26
  • Share Price
  • $5.38
  • (As of Monday Closing)

Roivant Sciences General Information

Description

Roivant Sciences Ltd is a biopharmaceutical company dedicated to improving the delivery of healthcare to patients.

Contact Information

Website
www.roivant.com
Formerly Known As
Valor Biotechnology
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Stock Exchange
NAS
Primary Office
  • 151 West 42nd Street
  • 15th Floor
  • New York, NY 10036
  • United States

Roivant Sciences Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Roivant Sciences Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$5.38 $5.66 $5.09 - $16.76 $3.92B 692M 575K
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Roivant Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Roivant Sciences‘s full profile, request access.

Request a free trial

Roivant Sciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Roivant Sciences Ltd is a biopharmaceutical company dedicated to improving the delivery of healthcare to patients.
Biotechnology
New York, NY
800 As of 2021
00.000
000000000 00.000

00000 00

irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Except
000000000000000
Ahmedabad, India
00000 As of 0000
000.00
000000 - 000 000.00

000000 0

x ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore
0000 000000000
South San Francisco, CA
00 As of 0000
00000
0.000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Roivant Sciences Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Intas Pharmaceuticals Private Equity-Backed Ahmedabad, India 00000 000.00 000000 - 000 000.00
000000 00000000000 Formerly PE-Backed South San Francisco, CA 00 00000 000000&0 00000
000000 Corporation Durham, NC 00 000.00 000000000 000.00
0000 0000000000000 Accelerator/Incubator Backed Kingston, Canada 0000000000
00000000 00000000 Corporate Backed or Acquired Bethlehem, PA 00 000000&0
You’re viewing 5 of 12 competitors. Get the full list »

Roivant Sciences Executive Team (27)

Name Title Board Seat Contact Info
Matthew Gline Chief Executive Officer & Board Member
Eric Venker MD Chief Operating Officer, Operations & President
Eric Venker MD Chief Operating Officer & President
Mayukh Sukhatme MD President & Chief Investment Officer, Investments
Benjamin Zimmer JD President
You’re viewing 5 of 27 executive team members. Get the full list »

Roivant Sciences Board Members (26)

Name Representing Role Since
000000 000000 SoftBank Group Board Member 000 0000
000000 00 Self Board Member 000 0000
000000 00 00.0 Self Board Member 000 0000
0000 00000 00 Axovant Sciences Board Member 000 0000
000000 00000 Axovant Sciences Board Member 000 0000
You’re viewing 5 of 26 board members. Get the full list »

Roivant Sciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Roivant Sciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Roivant Sciences‘s full profile, request access.

Request a free trial

Roivant Sciences Investments & Acquisitions (26)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 000000 30-Sep-2021 0000000000 Special Purpose Acquisition Company (SPAC)
0000000000 02-Aug-2021 0000 00000 Drug Discovery 0000000 0
00000000 28-Jul-2021 00 0000000 Medical Records Systems 0000000 0
0000000 00000 26-Feb-2021 0000000000 00000 Drug Discovery 0000000 0
Proteovant Therapeutics 06-Dec-2020 Merger/Acquisition 00000 Drug Discovery
You’re viewing 5 of 26 investments and acquisitions. Get the full list »

Ready to get started?

Request a free trial

Roivant Sciences Subsidiaries (4)

Company Name Industry Location Founded
Immunovant Drug Discovery New York, NY 2018
00000 0000000000 Biotechnology Oxford, United Kingdom 0000
000000000 00000000 Biotechnology Long Beach, CA 0000
0000000000 0000000 Drug Discovery Philadelphia, PA
To view Roivant Sciences’s complete subsidiaries history, request access »

Roivant Sciences Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000000 00000000 24-Apr-2019 0000000000 Completed
  • 5 buyers
00000000 00000000 12-Jul-2016 00000 0000000 Completed
  • 2 buyers
Axovant Sciences Early Stage VC Completed
  • 3 buyers
To view Roivant Sciences’s complete exits history, request access »